CBFB and neoplasm: The concept that gain-of-function mutations could contribute to tumor development or an aggressive phenotype is intriguing, as early studies on the RUNX/CBFβ relationship indicated that RUNX levels were tightly controlled whilst CBFβ expression was thought to be in abundance and depended on RUNX for translocation to the nucleus.